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The dendritic cell (DC) compartment comprises subsets of cells with distinct phenotypes.
Previously this lab reported methodology for hematopoiesis of dendritic-like cells in vitro
dependent on a murine splenic stromal cell line (5G3). Co-cultures of lineage-depleted bone
marrow (Lin− BM) over 5G3 continuously produced a distinct population of dendritic-like
“L-DC” for up to 35 days. Here the progenitor of L-DC is investigated in relation to known
BM-derived hematopoietic progenitors. It is shown here that L-DC-like cells also derive
from the CD150+Flt3− long-term reconstituting-hematopoietic stem cells (HSC), and also
from the Flt3+ multipotential progenitor subset in BM. Lin− BM co-cultures also produce a
transient population of cells resembling conventional (c) DC. Production of cDC-like cells is
shown here to be transient and M-CSF dependent, and also appears following co-culture
of described common dendritic progenitors or monocyte dendritic progenitors over 5G3.
BM cells from C57BL/6-flt3Ltm1lmx and C57BL/6-Csf2tm1Ard mice which lack cDC precur-
sors and monocytes, are shown here to contain L-DC progenitors which can seed 5G3
co-cultures. L-DC are functionally distinct cells, in that they arise independently of M-CSF,
and by direct differentiation from HSC.
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INTRODUCTION
Dendritic cells (DCs) are professional antigen presenting cells
required for induction of adaptive immune responses against
invading pathogens, and for maintaining tolerance to self anti-
gens. DC recognize and take up foreign substances via a number
of pathogen-specific receptors. Internalized native antigens are
then processed into small peptides, and displayed in the context
of major histocompatibility complex (MHC) Class I and Class II
molecules for activation of CD8+ and CD4+ T cells, respectively
(1, 2). Broadly, DC residing in lymphoid tissues can be catego-
rized as tissue resident DC or conventional (c) DC, plasmacytoid
(p) DC, migratory DC, and inflammatory DC (3). A complexity
of DC subsets enables the host to generate a range of immune
responses against harmful pathogens.
A distinct subset of dendritic-like cells, namely “L-DC,” was
recently characterized in murine spleen in the steady-state and
also produced in co-cultures of mouse spleen or bone marrow
(BM) cells over stroma (4–6, 31). L-DC express CD11b and CD11c
molecules on their cell surface, but not other DC markers such
as MHC-II, CD8α, or B220. Cells have high capacity to endocy-
tose antigen and to induce CD8 T cell activation (5, 8, 31). L-DC
produced in vitro or isolated from spleen have been shown to
have powerful capacity to cross-present antigen to CD8+ T cells
(7, 9). They can be distinguished functionally and phenotypically
from both DC and monocyte subsets in spleen (9). We have previ-
ously identified both BM and spleen as a source of hematopoietic
progenitors which can seed splenic stroma for L-DC production
(11–13, 31). Here the L-DC progenitor is investigated in detail in
relation to hematopoietic stem/progenitor cell subsets described
previously in BM. Development of L-DC from progenitors has also
been characterized in terms of dependency for known cytokines
which support the development of other known DC and myeloid
subsets.
Most DC in lymphoid tissues have a short life span and are
thought to be repopulated by committed progenitors arising in
BM. Myeloid and dendritic progenitors (MDP) were recently
described as c-kithiLin−Sca-1−Flt3+ cells which also express
CD115 and CX3CR1 (14, 15). Myeloid progenitors (MP) were
described as c-kithiLin−Sca-1−Flt3+ cells expressing CD115 but
not CX3CR1 (14, 15) and a common dendritic progenitor (CDP)
was identified in BM which produces both cDC and pDC (15,
16). The lineage relationship between L-DC with cDC/pDC was
addressed by sorting purified BM progenitors and assessing their
capacity to differentiate when co-cultured over the 5G3 stromal
line to give cDC, pDC, L-DC, and monocyte/myeloid cells. These
studies also tested the CD150+Flt3− subset of long-term (LT)
hematopoietic stem cells (HSC), and the CD150−Flt3+ subset of
short-term (ST)-HSC from BM, also referred to as multipotential
progenitors (MPP) (17–19).
Using splenic stromal co-cultures to induce differentiation of
dendritic-like cells from progenitors in BM, we have distinguished
the L-DC progenitor from known subsets of CDP, MDP, and MP,
confirming a distinct lineage origin for these cells. The produc-
tion of cDC-like cells in co-cultures is also described in terms of a
transient cell population which is distinct from L-DC.
MATERIALS AND METHODS
ANIMALS
Specific pathogen-free female C57BL/6J mice were bred at the
John Curtin School of Medical Research (JCSMR) (Canberra,ACT,
www.frontiersin.org January 2014 | Volume 4 | Article 501 | 1
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Petvises and O’Neill Identification of dendritic cell progenitors
Australia). B6.129P(Cg)-Ptprca Cx3cr1tm1Litt/LittJ mice (CX3CR1-
GFP) were purchased from Walter and Eliza Hall Institute (Mel-
bourne,VIC,Australia) (20). C57BL/6-flt3Ltm1lmx mice (Flt3L−/−)
(Taconic Farms Inc., NY, USA) were purchased from the Bio-
medical Research Facility, University of Western Australia (Perth,
WA, Australia) and C57BL/6-Csf2tm1Ard (GM-CSF−/−) mice (21)
were obtained from the Ludwig Institute for Cancer Research
(Melbourne, VIC, Australia). Animal housing, handling, and
experimentation was approved by the Animal Experimentation
Ethics Committee (Australian National University, Canberra,ACT,
Australia). Animals were sacrificed by cervical dislocation.
ANTIBODIES
Fluorochrome-conjugated antibodies specific for CD11c (N418),
CD11b (M1/70), CD115 (AFS98), and streptavidin-APC-Cy7 were
obtained from eBioscience (San Diego, CA, USA) or BioLe-
gend (San Gabriel, CA, USA). Fluorochrome-conjugated anti-
bodies specific for CD8α (53-6.7), B220 (RA3-6B2), MHC-II
(AF6-120.1), F4/80 (C1: A3-1), c-kit (2B8), Sca1 (E13-161.7),
Flt3 (A2F10), CD43 (1B11), Sirpα (P84), CD45RB (C363.16A),
CD150 (TC15-12F12.2), 4-1BBL (TKS-1), streptavidin-PE-Cy7,
streptavidin-PE, and streptavidin-FITC were obtained from
BioLegend (San Gabriel, CA, USA). Goat-anti rat-PE-Texas Red
was obtained from Invitrogen (Eugene, OR, USA). Isotype con-
trol antibodies including Rat IgG2a-FITC (R35-95), Rat IgG2b-
PE (RTK4530), Rat IgG2b-PE-Cy7 (eB149/10H5), Mouse IgG2a-
biotin (eBM2a), and Hamster IgG-APC (eBio299Arm) were
obtained from eBioscience.
CELL CULTURE AND REAGENTS
Cells were cultured in Dulbecco’s modified Eagles Medium
(DMEM) supplemented with 4 g/L d-glucose, 6 mg/L folic acid,
36 mg/L l-asparagine, 116 mg/L l-arginine, to which was added
10% fetal calf serum (FCS), 10 mM HEPES, 2 mM l-glutamine,
100 U/L penicillin, 100µg/L streptomycin, and 5× 10−5 M 2-
mercaptoethanol. The splenic stromal cell line 5G3 was passaged
every 4 days by scraping and transferring non-adherent cells to a
new flask (6). Cells were maintained in 5% CO2 in 95% humidity
at 37°C.
PREPARATION OF BM CELLS
Bone marrow was isolated by flushing femurs and tibias with 5 mL
of DMEM. Cells were centrifuged and resuspended in red blood
cell lysis buffer [140 mM NH4CL, 17 mM Tris Base (pH 7.5)]. Lin−
BM was prepared using a lineage depletion kit (Miltenyi Biotech,
Gladbach, Germany) and MACS® magnetic bead technology (Mil-
tenyi Biotech). The lineage depletion cocktail (Miltenyi Biotech)
comprised biotinylated antibodies specific for all hematopoietic
lineages (7–4, CD5, CD11b, B220, Ly6G/C, and Ter119). Anti-
body specific for CD11c (HL3: Becton Dickinson Pharmingen,
San Diego, CA, USA) was also added to deplete DC. Anti-biotin
microbeads in MS or LS columns (Miltenyi Biotech) were used to
purify Lin− cells.
CO-CULTURES OVER 5G3 STROMA
For establishment of co-cultures, Lin− BM or sorted hematopoi-
etic progenitors (104–5 cells/mL) were overlaid on to near-
confluent 5G3 stroma in replicate 25 cm2 flasks (5 mL). Medium
change was performed every 3–4 days by replacement of 2.5 mL
medium with 2.5 mL fresh, warmed complete medium. Non-
adherent cells produced in co-cultures were collected at days 14,
21, 28 and 35 for analysis of cell subsets produced. For inhibition
studies,104–5 cells/mL Lin− BM from C57BL/6J mice were overlaid
on to 5G3 stroma in the presence and absence of inhibitors. These
were titrated before use to find optimal inhibitory concentrations.
These included a M-CSFR inhibitor GW2580 used at 10 nM (Bio-
Vision, CA, USA), and a Flt3 inhibitor used at 0.5µM (Catalog
#343202: Merck KGa, Darmstadt, Germany). The Flt3 inhibitor is
a cell-permeable thienylcarboxamide compound which acts as a
potent ATP-competitive selective Flt3 inhibitor with little effect on
other kinases. In each case non-adherent cells were collected at days
14, 21, and 28 for analysis of cells produced. For Flt3 inhibition
experiments, cultures of Lin− BM supplemented with 200 ng/mL
Flt3L (eBioscience) were established as controls.
ISOLATION OF HEMATOPOIETIC PROGENITORS
Lin− BM was prepared as described above and then stained with
antibodies for delineation of progenitors for sorting. A cocktail
of antibodies (Miltenyi Biotech) was used to sort out Lin− BM
in order to further gate undifferentiated cells. This cocktail rec-
ognized BM-derived cells expressing CD3ε, Thy1.2, CD19, NK1.1,
Gr-1, CD11b, Ter119, MHC-II, or CD11c. LT-HSC were sorted as
the CD150+Flt3− subset of c-kit+Lin−Sca-1+ (KLS) cells (19);
MPP as CD150−Flt3+ KLS cells (19); MDP as Lin−Sca-1−c-
kithiFlt3+CD115+CX3CR1+ cells (14, 15); and MP as Lin−Sca-
1−c-kithiFlt3+CD115+CX3CR1− cells (14). In some experiments,
MDP were sorted as Lin−Sca-1−c-kithiFlt3+CD115+ cells (14)
and CDP as Lin−Sca-1−c-kitloFlt3+CD115+ cells (16, 22). Sort-
ing was performed on a FACS Aria II flow cytometer (Becton
Dickinson, Franklin Lakes, NJ, USA), and sorted cells reanalyzed
to check purity. Isotype control antibodies were used to set gates
and propidium iodide (PI: 1µg/mL) staining of cells was used
for dead cell discrimination. Sorted cells were washed twice and
overlaid on to 5G3 stroma for assessment of cell production.
ANALYSIS OF CELLS PRODUCED IN CO-CULTURES
Cells collected from co-cultures at each time point were stained
with antibodies specific to dendritic and myeloid cells. Briefly,
105–6 cells were firstly incubated with purified CD16/32 antibody
(Clone 93; eBioscience) for 15 min to block surface Fc receptors.
Cells were then washed with DMEM/1% FCS/0.1% NaN3 and
stained with primary antibodies specific for CD11c,CD11b, CD8α,
B220, and MHC-II for 20 min on ice. In some experiments, anti-
body to F4/80 and 4-1BBL were used to detect specific subsets
in co-cultures. Any secondary reagents were added to the stained
cells after a washing step, and further incubated for 20 min on ice.
Cells were finally washed twice and resuspended in DMEM/1%
FCS/0.1% NaN3 for flow cytometric analysis. Cells were stained
with PI (1µg/mL) for live cell discrimination. Cell acquisition
was performed using a LSR II flow cytometer (Becton Dickinson).
Between 5× 104 and 1× 106 events were collected for each sample.
Gates were set to delineate cell subsets using isotype control anti-
bodies and “fluorescence minus one” (FMO) controls. Cell subset
analysis was performed using BD FACSDiva Software (Becton
Dickinson) and FlowJo Software (Tristar; Phoenix, AZ, USA).
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STATISTICAL ANALYSIS
In some figures replicated data are presented as mean± SE (n= 3).
The Wilcoxon Rank Sum Test was used to test significance
(p< 0.05).
RESULTS
L-DC AND cDC-LIKE CELLS ARISE FROM DISTINCT PROGENITORS IN
BM
Previous reports from this lab showed that splenic stroma can sup-
port longterm development of L-DC from Lin− BM along with a
transient population of cDC-like cells (6, 8). To identify progeni-
tors of these distinct cell types, known hematopoietic progenitor
subsets in BM were sorted and overlaid on to 5G3 stroma to deter-
mine their differentiative capacity. Sorting involved gating Lin−
cells and delineation of progenitors differing in c-kit and Sca-1
expression. Subsets were further divided on the basis of expres-
sion of Flt3, CD150, and CD115 to give LT-HSC, MPP, CDP, and
MDP (Figure 1A). The MDP and CDP populations were distinct
as Flt3+CD115+ cells differing in level of c-kit expression. LT-HSC
and MPP differed in expression of CD150 and Flt3, and did not
express CD115.
Co-cultures established with LT-HSC, MPP, CDP, MDP, and
Lin− BM (as control) were maintained in triplicate, and cell
production analyzed weekly by staining non-adherent cells col-
lected at medium change for expression of CD11c, CD11b, B220,
CD8α, and MHC-II. Co-cultures produced only myeloid and den-
dritic cells (CD11b+,CD11c+) along with a progenitor-containing
(CD11b−, CD11c−) subset but no lymphoid lineage cells identi-
fiable by B220 or CD8α staining (Figure 1B). After 21 days, co-
cultures of LT-HSC produced CD11b+CD11c+MHC-II− L-DC-
like cells and a CD11b−CD11c− progenitor-like subset, while co-
cultures of CDP and MDP produced only CD11b+CD11c+MHC-
II+ cDC-like cells. Co-cultures of Lin− BM produced progeni-
tors, along with both dendritic-like subsets as reported previously
(6–8). MPP produced a majority of L-DC-like cells with 6.1%
cDC-like cells.
Production of cells from triplicate co-cultures was monitored
across 14, 21, 28, and 35 days. The reproducibility of the co-culture
system and of subset analysis by flow cytometry is indicated by
the low error obtained in assessing triplicate cultures. The rel-
ative proportion of progenitors (CD11b−CD11c−/lo) to mature
(CD11b+CD11c+) cells differed across co-cultures (Figure 2A).
LT-HSC co-cultures maintained>75% progenitors out to 35 days,
with all other co-cultures maintaining ≤25%, reaching zero by
35 days for all but MPP co-cultures. The absolute number of
cells produced also varied since progenitors varied in ability to
seed differentiation. LT-HSC co-cultures were distinct, with lower
overall production of CD11b+CD11c+ cells and a much higher
production of CD11b−CD11c−/lo progenitors (Figure 2A). Fur-
ther analysis of mature CD11b+CD11c+ cells distinguished the
MHC-II− L-DC-like and the MHC-II+ cDC-like subsets. LT-
HSC co-cultures produced only L-DC-like cells across 14–35 days
(Figure 2B) with almost no cDC-like cells. Lin− BM and MPP
co-cultures produced both cell types. MPP co-cultures showed
a clear majority of L-DC, while Lin− BM co-cultures produced
both cell types although the proportion of cDC-like cells declined
after 21 days. Co-cultures of MDP and CDP produced a high
proportion of cDC-like cells, with low L-DC production evident
by 35 days (Figure 2B). This could relate to the presence of low
numbers of contaminant L-DC progenitors amongst sorted CDP
and MDP. Similar data have been obtained over many replicate
experiments (all not shown), although the size of subsets has been
found to vary between mice, and with different starting popula-
tions of sorted cells. This variation is not huge, and affects the size
of subsets, rather than the representation amongst cells produced
in vitro.
As a further test of progenitor potential, MDP were sorted
on the basis of their expression of CX3CR1, which delineates
them from described MP (14, 15). Lin− BM from CX3CR1-GFP
mice was stained to isolate c-kithiFlt3+CD115+ cells differing
in expression of CX3CR1, so reflecting the MDP and MP sub-
sets (Figure 3A). These subsets were compared with Lin− BM
from CX3CR1-GFP mice for capacity to seed 5G3 co-cultures
(Figure 3B). Non-adherent cells were collected and analyzed flow
cytometrically at 14, 21, 28, and 35 days to delineate L-DC and
cDC-like cell production. Only MHC-II+ cDC-like cells were pro-
duced by MDP and MP co-cultures, with subsets of cDC-like cells
expressing CX3CR1 evident at 21 days (Figure 3C). By contrast,
Lin− BM produced an extra subset of MHC-II− L-DC, the major-
ity of which were CX3CR1− cells (Figure 3B). Co-cultures of MP
produced an overall twofold increase in production of cDC-like
cells over MDP co-cultures (Figure 3C). MDP and MP co-cultures
did not maintain CD11b−CD11c−/lo progenitors, nor support
production of CD11b+CD11c+MHC-II− L-DC (Figure 3C). Fur-
thermore, the production of CX3CR1+ cDC-like cells over similar
CX3CR1− cells increased over 35 days of co-cultures (Figure 3C).
One explanation for the presence of L-DC progenitors amongst
both the LT-HSC and MPP subsets is that the LT-HSC progenitor
undergoes differentiation and expression of Flt3 in co-cultures,
such that two closely related L-DC progenitors exist in BM dif-
fering in expression of Flt3. This hypothesis was proven correct
when a Flt3-specific inhibitor was added into co-cultures of LT-
HSC and MPP which are Flt3− and Flt3+ progenitors, respec-
tively. This inhibitor almost completely blocked the formation
of CD11b+CD11c+MHC-II−F4/80+ L-DC-like cells after 28 days
of co-culture, with cultures still retaining a high proportion of
CD11b−CD11c−/lo cells containing progenitors (Figures 4A,B).
This inhibitor also completely blocked development of cDC-like
cells in 28-day co-cultures established with sorted Flt3+ CDP, and
left the CD11b−CD11c−/lo progenitor-containing subset intact
(Figure 4C). In control Flt3-induced BM cultures, cDC produc-
tion was lost by 7 days (Figure 4D). This experiment was analyzed
at 28 days to allow more time to see the effect of inhibitors. How-
ever 28 days is the limit of co-culture reliability, and the absence
of CD11c upregulation between CD11b− and CD11b+ cells is
probably due to the downturn in cell development.
While others have reported pDC production in these cultures
(22), we have been unable to reproduce this finding using stain-
ing for CD11c, CD11b, MHC-II, and B220 (all data not shown)
(Figure 4D). The Flt3 inhibitor was not toxic to cultured cells since
there was no change in 5G3 stroma only cultures (data not shown).
The best evidence of non-toxicity of the Flt3 inhibitor in these
experiments is that the progenitor-containing CD11b−CD11c−/lo
subset was maintained at near control numbers (Figure 4E). These
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FIGURE 1 | Differentiative capacity of hematopoietic progenitors in
stromal co-cultures. (A) Lin− BM from C5BL/6J mice was stained with
antibodies to distinguish hematopoietic progenitors flow cytometrically. Cells
were initially stained with an antibody cocktail specific for CD3ε, CD4, CD5,
CD8α, B220, Gr-1, CD11b, Ter119, and CD11c to gate out Lin+ cells. Sca-1 and
c-kit staining was used to identify Lin−c-kithiSca-1+(LSK), Lin−c-kithiSca-1−, and
Lin−c-kitloSca-1− subsets. Staining with Flt3 and CD150 was used to
distinguish LT-HSC and MPP. These two subsets were tested for expression
of CD115 (red) in relation to isotype control (blue). CDP and MDP were
distinguished further on the basis of Flt3 and CD115 expression. Propidium
iodide (PI) staining was used to discriminate dead cells. Gates were set on
bivariate plots using isotype control antibodies and numbers on gates reflect
% positive cells. (B) Each of the progenitor subsets shown in (A) was sorted
and overlaid in 5G3 stromal co-cultures, with Lin− BM as a control. Cell
production was assessed over time using multicolor flow cytometry to
delineate cell subsets amongst non-adherent cells collected at medium
change. Data shows production of CD11b+CD11c+ cells gated amongst the
PI− live cell population at 21 days for one of three replicate cultures
established for each progenitor type. Cells were also tested for CD8α, B220,
and MHC-II staining as described in (A).
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FIGURE 2 | Differential production of dendritic-like cells in stromal
co-cultures established with different progenitors. Co-cultures were
established over 5G3 as in Figure 1. Cell production was assessed after 14,
21, 28, and 35 days using antibody staining and multicolor flow cytometry.
Cell production was assessed in terms of proportion of each subset, and
number of cells of each type produced. Graphs show mean±SE for triplicate
co-cultures. (A) Production of CD11b−CD11c−/lo and CD11b+CD11c+ cells.
(B) Production of CD11b+CD11c+ cells differing in expression of MHC-II. All
data for days 21, 28, 35, but only some 14 days data, are significantly different
(p≤0.05).
data confirm the importance of Flt3 signaling in L-DC develop-
ment from progenitors, as well as in the development of cDC,
although the latter arise from a distinct CDP which does not give
rise to L-DC.
FURTHER DEFINITION OF L-DC PROGENITORS
Further experiments addressed the question of whether pre-
cDC could seed co-cultures for hematopoiesis since co-
cultures of Lin− BM over 5G3 were found to produce
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FIGURE 3 | MDP and MP are progenitors of only cDC-like cells in
co-cultures. (A) BM from CX3CR1-GFP mice was stained with antibodies
and analyzed flow cytometrically for sorting MDP and MP as described in
Figure 1. Lin− cells were distinguished on a forward scatter (FSC) plot and
c-kithi cells gated to distinguish Flt3+ cells. These were then sorted as
CX3CR1+ and CX3CR1− subsets of MP and MDP, respectively, each of
which showed CD115 staining. (B) Sorted cells were co-cultured over 5G3
stroma using Lin− BM as a control. Non-adherent cells were collected from
co-cultures at different time points and stained for CD11c, CD11b, MHC-II,
and CD8α to detect production of CD11b+CD11c+CD8α−B220−MHC-II−
L-DC and CD11b+CD11c+CD8α−B220−MHC-II+ cDC-like cells, and their
expression of CX3CR1. Data shown reflect cells produced at 21 days.
(C) Cell production was calculated in terms of number of cells of each type
produced. Graphs show mean±SE for triplicate co-cultures.
Lin−CD45RB+CD43loSirpαlo cells described previously as pre-
cDC (22, 23) (Figure 5A). The presence of a Lin−c-
kit+Sca1+CD11cloFlt3− subset was also considered indicative
of DC precursors. When Lin−CD45RB+CD43loSirpαlo pre-cDC
were sorted out of BM (Figure 5B) and overlaid on 5G3 in co-
cultures, they were however unable to produce either cDC-like or
L-DC-like cells after 14 days, a result which emphasizes their more
advanced differentiative state (Figure 5C).
In order to further distinguish the functional potential of L-DC
in relation to cDC-like cells, Lin− BM from Flt3L−/− and GM-
CSF−/− mice, and from syngeneic control C57BL/6J wild-type
(WT) mice were tested for differentiative capacity in 5G3 co-
cultures. These mice have very reduced numbers of cDC and
pDC and significantly fewer progenitors of cDC and pDC in BM
(24). Subset analysis of spleen has revealed that the L-DC sub-
set is present in both of these strains (unpublished data). Cell
production was monitored flow cytometrically by staining cells
collected from triplicate co-cultures for CD11b, CD11c, MHC-II,
4-1BBL, F4/80, B220, and CD8α (Figure 6A). CD11b+CD11c+
cells were gated for analysis of production of MHC-II− L-DC
and MHC-II+ cDC-like cells. In this experiment involving Lin−
BM overlays, the total yield of cells was equivalent across co-
cultures limited only by the culture system. The production of
cells is therefore only presented in terms of % cells of each subset.
WT co-cultures at 21 days showed a majority (~60%) popula-
tion of MHC-II− L-DC distinguishable from a smaller population
(~20%) of MHC-II+ cDC-like cells, by F4/80 and 4-1BBL expres-
sion (Figure 6A). Expression of 4-1BBL is also consistent with the
capability of L-DC to induce CD8+ T cell activation and prolifera-
tion (25). Again, only the two types of cells were produced with no
evidence of B220+ pDC or CD8α+ cDC. A comparison of mutant
and WT co-cultures also revealed loss of CD11b+CD11c−myeloid
precursors in BM of Flt3L−/− and GM-CSF−/− mice. This was
evident in terms of reduction in the proportion of myeloid versus
dendritic-like cells produced over time (Figure 6B). The DC pop-
ulation arising from progenitors in Flt3L−/− and GM-CSF−/− BM
cultured over 5G3 stroma was exclusively L-DC (Figure 6B). This
study served to distinguish the progenitors of cDC from those
of L-DC, and to further distinguish L-DC as F4/80+4-1BBL+
cells. The reproducibility of results is again represented by the
smaller error values achieved by staining cells produced in tripli-
cate co-cultures. These findings are consistent with former reports
showing a shortage of cDC precursors in mice harboring Flt3
and Flt3L mutations (24, 26). A smaller reduction in production
of cDC-like cells in GM-CSF−/− co-cultures supported evidence
that GM-CSF is dispensable for DC development (24).
M-CSF PRODUCED BY STROMA IS ESSENTIAL FOR DEVELOPMENT
OF ONLY cDC-LIKE CELLS
Previously M-CSF has been shown to support the development
of cDC and pDC in vitro, and to increase the production of these
cells in vivo, particularly in Flt3L−/−mice which have very reduced
numbers of mature cDC and pDC (27). The functional impor-
tance of M-CSF produced by 5G3 stroma (28) was therefore tested
by inclusion of the GW2580 inhibitor of M-CSFR (29) in co-
cultures established with Lin− BM. Inhibitor was maintained in
co-cultures out to 28 days. The production of cells was monitored
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FIGURE 4 | Importance of Flt3 signaling for hematopoiesis in
co-cultures. (A) LT-HSC, (B) MPP, and (C) CDP were sorted from BM
of C57BL/6J mice as in Figure 1, and established in co-cultures above
5G3 stroma in the presence and absence of Flt3 inhibitor. After 28 days
cell production was assessed by staining with antibodies to CD11c,
CD11b, F4/80, and MHC-II and flow cytometric gating of
CD11c+CD11b+ cells and their MHC-II− (L-DC) and MHC-II+ (cDC-like
cell) subsets. (D) Control BM cultures were established with Flt3L in
the presence and absence of the Flt3 inhibitor, and production of
CD11c+CD11b+ cells was determined after 7 days. (E) Production of
different cell types for each of the co-cultures is shown in terms of
absolute number of cells produced.
and found to be equivalent across all co-cultures as common
in Lin− BM co-cultures. The proportion of L-DC and cDC-like
cells produced was monitored flow cytometrically and the data
presented as % cells of each type in terms of mean± SE of trip-
licates. In the absence of GW2580, these co-cultures produced a
large subset of CD11b+CD11c+MHC-II+ cDC-like cells. The 50–
60% subset of cDC-like cells maintained for 28 days was however
reduced to a 6–8% population in co-cultures containing GW2580
(Figure 7A). This particular experiment was selected out of sev-
eral replicates for presentation based on its higher production of
cDC-like cells compared with L-DC. Differences in the propor-
tion of these cell types can occur and appear to reflect age-related
and individual animal effects. Co-cultures treated with inhibitor
showed an increase in the proportion of CD11b+CD11c−myeloid
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FIGURE 5 | Investigation of pre-cDC production in co-cultures. The
presence of pre-cDC was investigated in (A) cells collected from 14-day
co-cultures of C57BL/6J Lin− BM over 5G3 stroma, and in (B) C57BL/6J
BM. Progenitors were gated as a Lin− subset using FSC and SSC plots.
Pre-cDC were detected by staining for c-kit, Sca-1, Flt3, CD11c,
CD45RB, CD43, and Sirpα. Propidium iodide (PI) was added to allow
gating of PI− live cells. Gates were set on bivariate plots using isotype
control antibodies, and numbers on gates reflect % positive cells. Using
the gating strategy shown in (B), pre-cDC were sorted out of BM for
co-culture above 5G3 stroma. (C) Production of dendritic-like cells in
pre-cDC co-cultures was assessed in relation to Lin− BM co-cultures
after 14 days following gating of large cells on a bivariate CD11c versus
CD11b plot, and analysis of expression of CD11c, CD11b, MHC-II, and
CD8α.
precursors, with a concomitant reduction in the proportion of
CD11b+CD11c+ cells (Figure 7B). The progenitor-containing
subset of CD11b−CD11c−/lo was consistently low. L-DC produced
in co-cultures with added inhibitor were detectable on the basis
of their unique expression of 4-1BBL, F4/80, and absence of
MHC-II. The relative proportion of these cells increased to near
100% in co-cultures containing inhibitor. While cDC-like cells
produced in 5G3 stromal co-cultures are dependent on M-CSF
for development, L-DC are clearly not.
DISCUSSION
This study focuses on the developmental origin of two function-
ally distinct dendritic-like cell types produced in vitro over splenic
stroma. The 5G3 stromal line as a supporter of hematopoiesis is
unique and under independent investigation in relation to stro-
mal elements which form microenvironments for hematopoiesis
in BM. A single main cell type namely “L-DC” is produced in co-
cultures of BM over 5G3 stroma. L-DC are novel as MHC-II−
DC with high capacity for endocytosis of antigen and cross-
presentation with activation and proliferation of CD8+ T cells
but not CD4+ T cells (5, 8, 9). Co-cultures of mixed BM however
also show transient production of cells reflective of cDC (6–8).
These findings raise the possibility that spleen may play a role in
myelopoiesis in addition to its dominant role in erythropoiesis.
This possibility is made more likely due to evidence that spleen
contains a phenotypically and functionally similar “L-DC” subset
with similar high endocytic capacity and capacity for strong acti-
vation of CD8+ T cells but no or weak activation of CD4+ T cells
(9). It is this latter property of cross-presentation, along with cell
morphology and CD11c expression which has led to classification
of this cell as dendritic-like rather than myeloid or macrophage-
like. L-DC do not express markers of splenic macrophages like
MOMA-1, CD68, and SIGNR1, although they more closely resem-
ble residential and inflammatory monocytes. Their relationship
with inflammatory or residential macrophages, which do not
cross-present antigen, is under further investigation. The impor-
tant role of distinct antigen presenting cells in a variety of immune
responses justifies our further characterization of the L-DC subset.
The progenitors of both L-DC and cDC-like cells produced
in co-cultures have been investigated here with a view to deter-
mining their lineage origin in relation to other previously defined
dendritic and myeloid cell types. Co-cultures initiated with known
HSPC subsets sorted from BM show differential capacity to pro-
duce the distinct L-DC and cDC-like subsets which are produced
together in co-cultures established with a heterogeneous Lin− BM
subset (7, 10). Both MDP, as progenitors of monocytes and DC, as
well as CDP, the more restricted progenitor of cDC and pDC, both
produce only cDC-like cells in co-cultures. This distinguishes L-
DC immediately from the more common DC lineage comprising
CD8+ cDC, CD8− cDC, and pDC subsets which constitute the
largest subsets of DC present in spleen. MDP were also isolated
along with the earlier MP on the basis of differential expression
of CX3CR1, and these progenitor subsets both produced only
cDC-like cells, with no evident maintenance of progenitors within
co-cultures. All of this evidence serves to distinguish L-DC as a cell
type distinct from the common myeloid and DC lineages. The like-
ness of co-culture derived cDC-like cells to commonly described
cDC is based on phenotypic and functional similarity, i.e., capac-
ity of those cells to activate CD8+ and CD4+ T cells (10). Over
many repeat experiments we have never recorded the production
of CD8+ cDC or of B220+ pDC in 5G3 stromal co-cultures.
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FIGURE 6 | BM from Flt3L−/− and GM-CSF−/− mice contains progenitors of
L-DC but not cDC-like cells. Lin− BM prepared from C57BL/6J (WT), Flt3L−/−,
and GM-CSF−/− mice, was overlaid on 5G3 stroma and cell production
monitored weekly for 5 weeks. (A) Non-adherent cells were stained with
antibody to detect a CD11b+CD11c+ population of dendritic-like cells, then
tested for expression of MHC-II, 4-1BBL, F4/80, CD8α, and B220. Data shows
cell production at 21 days for one of three replicate cultures established from
different mice. Gates were set on bivariate plots using isotype control
antibodies and numbers on gates reflect % positive cells. (B) Co-cultures
were analyzed over time for production of CD11b+ cells differing in expression
of CD11c, and for production of CD11c+CD11b+ cells differing in expression of
MHC-II. Proportion of each subset is shown as mean±SE for triplicate
co-cultures. All data are significantly different (p≤0.05), with several
exceptions: WT on days 14 and 21, and GM-CSF−/− on day 14.
Long-term hematopoietic stem cells, isolated out of BM
as a CD150+Flt3−c-kit+Lin−Sca-1+ subset (19), yielded only
L-DC-like cells in co-cultures along with a high frequency of
progenitors. Stroma appears to support restricted and direct dif-
ferentiation of LT-HSC to L-DC. The L-DC progenitor appears
to be maintained in co-cultures for extended periods of 5 weeks
shown here, and up to 6 months (data not shown). The MPP,
which is a progenitor subset immediately downstream of LT-HSC,
also produces predominantly L-DC-like cells in co-cultures. Either
the same progenitor must be present in both subsets which dif-
fer by expression of Flt3 and CD150, or two distinct progenitors
must exist, one being the derivative of the other. This finding is
consistent with a study showing that all hematopoietic lineages
develop through a Flt3+ intermediate, the expression of which
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FIGURE 7 | M-CSFR inhibitor selectively inhibits development of
cDC-like cells but not L-DC. Lin− BM from C57BL/6J mice was co-cultured
with 5G3 stroma in the absence or presence of 10 nM GW2580, an inhibitor
of M-CSFR, added again to cultures at medium change every 3–4 days.
(A) Cell production was analyzed at 14, 21, and 28 days, by staining cells for
CD11c, CD11b, MHC-II, 4-1BBL, F4/80, and CD8α, followed by flow
(Continued)
FIGURE 7 | Continued
cytometric analysis. Propidium iodide staining was used to delineate live
(PI−) cells, which were then gated on CD11c and CD11b using isotype
controls to set gates. L-DC were then distinguished from cDC-like cells on
the basis of expression of 4-1BBL, F4/80, and the absence of MHC-II
expression. (B) Co-cultures were analyzed over time for production of
CD11b+ cells differing in expression of CD11c, and for production of
CD11c+CD11b+ cells differing in expression of MHC-II. Proportion of each
subset is shown as mean±SE for triplicate co-cultures. All data are
significantly different (p≤0.05).
demarcates the loss of self-renewal capacity amongst HSC (30).
Indeed by using a Flt3 inhibitor we demonstrated the functional
importance of Flt3 signaling in the development of L-DC such
that the Flt3− LT-HSC subset must have acquired Flt3 expres-
sion during co-culture. A role for Flt3L in L-DC development
is predicted, but is not supported by evidence for high produc-
tion of Flt3L by 5G3 (data in preparation). The production of
Flt3L by 5G3, as well as the possibility of alternate ligands for
Flt3, are under further consideration. Further experiments have
also distinguished the developmental origin of L-DC by lack
of progenitor expression of CD115, and lack of dependency on
M-CSF.
L-DC progenitors in BM were investigated in relation to the
known CDP, MDP, MP, and HSC progenitors described previously.
However our previous studies have also partially characterized the
L-DC progenitor in spleen as a Lin−c-kitlo subset reflecting HSC
(11, 13, 31). Indeed, spleen does contain low numbers of HSC
which can fully reconstitute the hematopoietic system of irradi-
ated mice and also give rise to L-DC (7, 11, 32). By comparison
with the in vitro co-culture studies described here, the in vivo
reconstitution studies revealed multilineage development and no
restricted differentiation of L-DC (30, 32). However, those studies
did show clear evidence of a predominance of L-DC amongst all
DC produced in spleen, suggesting that the splenic microenviron-
ment may be more conducive to L-DC development (30, 31, 33).
The possibility that L-DC reflect an antigen presenting cell type
endogenous to spleen is therefore under further investigation.
Overall, this study demonstrates that the progenitor of L-DC
is distinct from the common progenitor of DC (CDP), mono-
cytes/DC (MDP), and myeloid cells (MP) present in BM. In
5G3 co-cultures, L-DC-like cells can be differentiated directly
from the earliest self-renewing HSC, the LT-HSC, while cDC-
like cells require MP, MDP, or CDP to maintain their numbers
within co-cultures. L-DC development is also functionally distin-
guished since it occurs independently of M-CSF and GM-CSF,
while these factors influence the development of cDC-like cells
in co-cultures and in normal development in the animal. While
in vitro studies may not exactly reflect in vivo development, it
is notable that the well described in vivo subsets of cDC and
pDC can be generated in cultures dependent on Flt3L (22), and
monocyte-derived DC can be generated in vitro in the presence of
GM-CSF (34). M-CSF-dependent cultures have also been shown
to generate cells resembling cDC and pDC (27). Since the in vivo
equivalent of L-DC has been partially characterized in murine
spleen (9), the production of similar cells in vitro does not appear
artifactual.
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